An incubator supporting Jordanian entrepreneurs with workspace and early-stage mentorship.
About iPark
iPark is a Jordanian incubator based in Amman that supports early-stage entrepreneurs with workspace, mentorship, and modest pre-seed capital in the sub-$250K range. The vehicle is operated under the umbrella of the Royal Scientific Society and is best understood as a foundational launchpad for Jordanian founders rather than as a venture investor in the institutional sense. Within healthcare, iPark engages with digital health founders at the very earliest stages, providing the operational scaffolding that lets a team build a working prototype and validate initial customer hypotheses inside the Jordanian healthcare ecosystem. The geographic focus is exclusively Jordan, with some pathways into the broader Levant for graduates of the program. The right founder profile is an early-stage Jordanian founder, ideally a technical founder coming out of the Royal Scientific Society research community or a returning diaspora entrepreneur, who needs structured early support to translate a concept into an early product. The wrong fit is a Series A-ready company with established traction; iPark’s value is concentrated at idea-to-prototype rather than commercial scaling. The right entry path is through iPark’s open application process for its incubator cohorts, through the Royal Scientific Society’s broader research and entrepreneurship ecosystem, and through Jordanian university programs at JU and PSUT. When pitching, lead with the founder’s commitment to building in Jordan, the technical credibility of the team, and the early customer hypothesis, then connect to the regional expansion logic that justifies the company over time. Caveats: iPark is a relatively small program with limited follow-on capacity, and Jordanian healthtech founders should plan for institutional Series A capital from regional firms like Sawari, BECO Capital, MEVP, or the Saudi institutional ecosystem as the next step. The Jordanian market alone is too small to support a venture-scale outcome, so a credible regional or international expansion thesis is essential by the time the company graduates. Use iPark as the local launchpad that gets your Jordanian healthtech company started and creates inbound from regional Series A investors once the metrics warrant it.
Founder reviews
Healthcare AI tools backed by iPark
Tools made by companies in iPark's portfolio that we cover in the directory.
Portfolio companies in our directory
Other portfolio companies
Companies in iPark's portfolio not currently in our directory.
- AllCellTech
Team
Pitch / review this investor
Have you raised from iPark? Founders only — share your honest experience (anonymous OK, moderated before publishing).

